Table 2

Numbers and proportions of patients taking ACE inhibitor or ARB medication according to patient characteristics

CategoryNumber in categoryPrescribed ACE inhibitor (row %)Prescribed ARB (row %)
Total population8 275 949645 577 (7.80)308 881 (3.73)
Male4 115 973375 509 (9.12)145 181 (3.53)
Female4 159 976270 068 (6.49)163 700 (3.94)
Age (years)
 20–393 135 98010 921 (0.35)3635 (0.12)
 40–491 399 56244 117 (3.15)14 746 (1.05)
 50–591 386 093125 971 (9.09)46 885 (3.38)
 60–691 037 077163 430 (15.76)74 343 (7.17)
 70–79802 224176 435 (21.99)95 393 (11.89)
 80+515 013124 703 (24.21)73 879 (14.35)
Material deprivation
 Quintile 1 (most affluent)1 877 761177 329 (9.44)92 484 (4.93)
 Quintile 21 819 942161 223 (8.86)80 220 (4.41)
 Quintile 31 671 924130 505 (7.81)60 006 (3.59)
 Quintile 41 490 725101 993 (6.84)44 660 (3.00)
 Quintile 5 (most deprived)1 415 59774 527 (5.26)31 511 (2.23)
Ethnicity
 White/not recorded6 960 062575 787 (8.27)264 990 (3.81)
 Indian228 46714 185 (6.21)9936 (4.35)
 Pakistani147 39710 198 (6.92)5656 (3.84)
 Bangladeshi110 3688189 (7.42)4134 (3.75)
 Other Asian146 1748000 (5.47)5259 (3.60)
 Caribbean93 9497478 (7.96)5358 (5.70)
 Black African199 2009379 (4.71)6017 (3.02)
 Chinese82 9841460 (1.76)1112 (1.34)
 Other ethnic group307 34810 901 (3.55)6419 (2.09)
Geographical region
 East Midlands216 53514 004 (6.47)6016 (2.78)
 East of England296 23624 270 (8.19)11 998 (4.05)
 London2 080 923112 569 (5.41)58 961 (2.83)
 North East194 02717 597 (9.07)6370 (3.28)
 North West1 471 787137 043 (9.31)61 705 (4.19)
 South Central1 104 11489 462 (8.10)42 668 (3.86)
 South East927 20879 871 (8.61)43 932 (4.74)
 South West899 72275 767 (8.42)32 850 (3.65)
 West Midlands781 29770 613 (9.04)33 605 (4.3)
 Yorkshire and Humber304 10024 381 (8.02)10 776 (3.54)
Smoking status
 Never smoker4 745 455335 769 (7.08)181 411 (3.82)
 Ex-smoker1 774 275227 398 (12.82)103 363 (5.83)
 Light smoker1 109 15462 039 (5.59)18 364 (1.66)
 Moderate smoker213 62911 542 (5.40)3332 (1.56)
 Heavy smoker98 7487929 (8.03)2011 (2.04)
 Smoking not recorded334 688900 (0.27)400 (0.12)
Body mass index (BMI)
 BMI <20 kg/m2 543 34713 050 (2.40)5153 (0.95)
 BMI 20–24.99 kg/m2 2 438 268115 952 (4.76)50 968 (2.09)
 BMI 25–29.99 kg/m2 2 344 187231 282 (9.87)109 202 (4.66)
 BMI 30–34.99 kg/m2 1 090 042158 175 (14.51)79 933 (7.33)
 BMI 35+ kg/m2 619 487108 568 (17.53)55 489 (8.96)
 BMI not recorded1 240 61818 550 (1.50)8136 (0.66)
Concurrent morbidity
 Chronic renal disease338 693103 643 (30.60)65 255 (19.27)
 Asthma1 089 64583 948 (7.70)4927 (4.52)
 COPD195 11543 288 (22.19)21 063 (10.80)
 Cardiovascular disease433 631165 415 (38.15)71 472 (16.48)
 Atrial fibrillation201 91161 332 (30.38)32 330 (16.01)
 Congestive cardiac failure97 11843 746 (45.04)21 637 (22.28)
 Type 1 diabetes39 0948316 (21.27)2989 (7.65)
 Type 2 diabetes536 516193 155 (36.00)88 308 (16.46)
 Hypertension diagnosis1 414 021536 002 (37.91)274 784 (19.43)
 Monotherapy773 675230 565 (29.80)105 921 (13.69)
 Dual therapy516 178293 187 (56.80)138 397 (26.81)
 Triple therapy190 856121 825 (63.83)64 563 (33.83)
 Long-term medication
 ACE inhibitor645 5774119 (0.64)
 ARB308 8814119 (1.33)
 Beta-blockers525 149189 691 (36.12)86 126 (16.40)
 Calcium channel blockers654 171241 203 (36.87)119 143 (18.21)
 Other diabetes drugs151 07465 933 (43.64)29 245 (19.36)
 Sulfonylureas98 90843 836 (44.32)18 591 (18.80)
 Biguanides328 387135 263 (41.19)57 509 (17.51)
 Anticoagulants207 06166 374 (32.06)33 889 (16.37)
 Antiplatelets410 816169 770 (41.33)73 938 (18.00)
 Statins1 073 039388 769 (36.23)173 983 (16.21)
 Thiazides220 14396 311 (43.75)55 142 (25.05)
 Potassium-sparing diuretics46 82520 660 (44.12)11 807 (25.22_
  • ARB, angiotensin receptor blocker; COPD, chronic obstructive pulmonary disease.